Neuroendocrine carcinoma is a complex and rare type of cancer that develops from specialized cells combining nerve and hormone-producing functions. Understanding treatment approaches—from established medical therapies to promising investigational drugs being tested in clinical trials—can help patients and families navigate this challenging diagnosis with greater confidence and hope.

Understanding Treatment Goals and Approaches

When doctors develop a treatment plan for neuroendocrine carcinoma, they focus on multiple objectives that depend heavily on the specific characteristics of each person’s cancer. The primary goals often include controlling tumor growth, managing symptoms caused by excess hormone production, preventing the cancer from spreading to other organs, and ultimately improving quality of life and survival^[1]. Unlike some other cancers, neuroendocrine carcinoma presents unique challenges because these tumors can behave very differently from one patient to another.

Treatment decisions are never one-size-fits-all. Doctors carefully consider where the cancer started in the body, how fast the cancer cells are growing and dividing (called the grade), how far the disease has spread (the stage), and whether the tumor is releasing hormones that cause symptoms^[3]. A tumor that produces excessive amounts of hormones is called a functional neuroendocrine carcinoma, while one that doesn’t release enough hormones to cause problems is termed non-functional^[2]. These distinctions matter enormously because they influence which treatments will work best.

The medical community has established standard treatment protocols based on years of research and clinical experience. These approved therapies have been carefully studied and endorsed by medical societies and regulatory agencies. At the same time, researchers continue to explore new treatment options through clinical trials, testing innovative drugs and approaches that may offer hope for patients whose disease hasn’t responded to standard therapies or who are looking for potentially more effective options^[4].

Standard Treatment Approaches

Surgery remains one of the most important treatment options for neuroendocrine carcinoma when the cancer is localized and can be completely removed. Surgeons aim to take out the entire tumor along with some surrounding healthy tissue and nearby lymph nodes to reduce the chance of cancer returning^[10]. For patients whose cancer has spread extensively, surgery may still play a role—not to cure the disease, but to reduce tumor burden and relieve symptoms such as pain or obstruction of organs. This approach, called debulking, can significantly improve comfort and quality of life even when complete removal isn’t possible^[11].

Chemotherapy is a cornerstone treatment for neuroendocrine carcinomas, particularly because these are fast-growing cancers. Chemotherapy uses powerful anti-cancer drugs that travel throughout the body to attack rapidly dividing cancer cells wherever they may be^[13]. The specific chemotherapy drugs and combinations used depend on where the cancer started and how aggressive it appears under the microscope. Common chemotherapy regimens may include combinations of drugs that have proven effective against neuroendocrine carcinomas in clinical studies. Treatment is typically given in cycles, with periods of treatment followed by rest periods to allow the body to recover from side effects.

The side effects of chemotherapy can be challenging and vary depending on which drugs are used. Patients may experience fatigue, nausea and vomiting, loss of appetite, hair loss, increased risk of infections due to lowered white blood cell counts, and numbness or tingling in hands and feet^[5]. While these effects can be uncomfortable, many can be managed with supportive medications and typically improve once treatment is completed. Your healthcare team will monitor you closely throughout chemotherapy and adjust treatment as needed to balance effectiveness with tolerability.

For some patients with functional neuroendocrine carcinomas that produce excess hormones, doctors may prescribe somatostatin analogues. These are medications given as monthly injections that work by mimicking a natural hormone called somatostatin, which helps regulate hormone production in the body^[14]. Common drugs in this class include lanreotide and octreotide. These medications can reduce hormone levels, control symptoms like flushing, diarrhea, and rapid heartbeat, and in some cases may also slow tumor growth. Somatostatin analogues are generally well tolerated, with side effects that may include mild digestive upset, injection site reactions, and occasionally gallstones with long-term use^[13].

Radiation therapy uses high-energy beams to destroy cancer cells in specific areas of the body. While not always the primary treatment for neuroendocrine carcinomas, radiation can be extremely valuable in certain situations^[13]. It may be used after surgery to eliminate any remaining cancer cells, to treat cancer that has spread to bones or the brain where it’s causing pain or other symptoms, or to shrink tumors that are pressing on important structures. Modern radiation techniques allow doctors to target tumors very precisely while minimizing damage to surrounding healthy tissue.

Innovative Treatments in Clinical Trials

Clinical trials represent the frontier of cancer treatment, offering access to promising new therapies that aren’t yet widely available. For neuroendocrine carcinomas, researchers are actively testing several innovative approaches that may improve outcomes for patients^[4]. Understanding how clinical trials work can help patients decide whether participation might be right for them.

Clinical trials proceed through distinct phases, each designed to answer specific questions. Phase I trials primarily focus on safety, determining the right dose of a new drug and identifying potential side effects in small groups of patients. Phase II trials expand to larger groups to evaluate whether the treatment actually works against the cancer and to further assess safety. Phase III trials involve even larger numbers of patients and compare the new treatment directly with current standard therapies to determine which approach works better^[14].

Peptide Receptor Radionuclide Therapy (PRRT) represents one of the most significant advances in treating neuroendocrine cancers in recent years. This sophisticated treatment combines a targeting molecule that attaches specifically to receptors found on neuroendocrine cancer cells with a radioactive particle that delivers radiation directly to those cells^[14]. The drug is administered through an intravenous infusion, typically given in four doses spaced eight weeks apart. Because PRRT delivers radiation directly to cancer cells throughout the body, it can treat tumors wherever they may be while causing fewer side effects than traditional chemotherapy. Patients receiving PRRT generally tolerate it well, though some may experience temporary fatigue, nausea, or changes in blood counts. This therapy has shown promising results in clinical trials, with many patients experiencing tumor shrinkage or stabilization and improvement in symptoms^[11].

Targeted therapy drugs work differently from traditional chemotherapy. Instead of attacking all rapidly dividing cells, these medications target specific molecular pathways that cancer cells use to grow and survive. For neuroendocrine carcinomas, researchers are studying drugs called tyrosine kinase inhibitors and mTOR inhibitors^[11]. These drugs interfere with signals that tell cancer cells to divide and with the formation of new blood vessels that tumors need to grow. Tyrosine kinase inhibitors like sunitinib and pazopanib work by blocking multiple enzymes involved in tumor growth. The mTOR inhibitor everolimus targets a specific protein pathway that regulates cell growth and metabolism. Clinical trials have shown that these targeted drugs can slow disease progression in some patients with advanced neuroendocrine carcinomas, particularly those whose cancer has continued to grow despite other treatments.

Immunotherapy harnesses the power of the body’s own immune system to fight cancer. The immune system normally recognizes and destroys abnormal cells, but cancer cells can sometimes evade this defense. Immunotherapy drugs help remove the brakes on the immune system or enhance its ability to recognize cancer cells^[11]. Checkpoint inhibitors, a type of immunotherapy, work by blocking proteins that prevent immune cells from attacking cancer. While immunotherapy has revolutionized treatment for some cancers, its role in neuroendocrine carcinomas is still being defined through ongoing clinical trials. Researchers are particularly interested in understanding which patients with neuroendocrine carcinomas are most likely to benefit from these treatments.

Clinical trials for neuroendocrine carcinomas are being conducted at specialized cancer centers throughout the United States, Europe, and other regions^[14]. Eligibility for specific trials depends on many factors, including the location and extent of cancer, previous treatments received, overall health status, and specific characteristics of the tumor itself. Patients interested in clinical trials should discuss options with their oncology team, who can help identify appropriate studies and explain the potential risks and benefits of participation.

Specialized Interventional Procedures

For patients whose neuroendocrine carcinoma has spread to the liver, specialized procedures performed by interventional radiologists can offer significant benefits. Trans-arterial embolization (TAE) is a technique where a doctor inserts a thin tube called a catheter into blood vessels leading to liver tumors and then injects substances that block blood flow to the cancer^[13]. Since tumors need a steady blood supply to grow, cutting off this supply can shrink tumors or prevent them from growing larger. This procedure is typically done while the patient is under sedation, and most people can go home the same day or after an overnight stay.

Radiofrequency ablation (RFA) and microwave ablation use heat energy to destroy cancer cells in the liver. During these procedures, a specialist inserts a thin needle through the skin into the tumor, guided by imaging such as ultrasound or CT scan^[13]. The needle then delivers either radiofrequency energy or microwave energy that heats and kills the cancer cells. These techniques work best for smaller tumors and can be repeated if new tumors appear. Recovery is generally quick, and these procedures avoid the need for major surgery in carefully selected patients.

Most common treatment methods

• Surgery
  • Removal of primary tumor and affected lymph nodes when cancer is localized
  • Debulking surgery to reduce tumor burden and relieve symptoms in advanced disease
  • Performed by experienced surgical oncologists, often using minimally invasive techniques when possible
• Chemotherapy
  • Cornerstone treatment for fast-growing neuroendocrine carcinomas
  • Uses combinations of anti-cancer drugs that target rapidly dividing cells throughout the body
  • Given in cycles with rest periods to allow recovery from side effects
• Somatostatin Analogues (Hormonal Therapy)
  • Monthly injections of lanreotide or octreotide for functional tumors producing excess hormones
  • Controls hormone-related symptoms and may slow tumor growth
  • Often first-line therapy for low to intermediate grade neuroendocrine tumors
• Radiation Therapy
  • High-energy beams delivered externally to destroy cancer cells in specific areas
  • Used after surgery, for symptom relief, or to treat metastases in bones or brain
  • Modern techniques allow precise targeting with minimal damage to healthy tissue
• Peptide Receptor Radionuclide Therapy (PRRT)
  • Combines targeting molecule with radioactive particle delivered through IV infusion
  • Typically given in four doses spaced eight weeks apart
  • Delivers radiation directly to cancer cells with fewer side effects than traditional chemotherapy
• Targeted Therapy
  • Tyrosine kinase inhibitors like sunitinib and pazopanib that block enzymes involved in tumor growth
  • mTOR inhibitors such as everolimus that interfere with cell growth pathways
  • Work by targeting specific molecular mechanisms cancer cells use to survive and multiply
• Immunotherapy
  • Checkpoint inhibitors that remove brakes on immune system to help fight cancer
  • Role in neuroendocrine carcinomas still being defined through clinical trials
  • May benefit select patients whose tumors have specific characteristics
• Interventional Radiology Procedures
  • Trans-arterial embolization (TAE) blocks blood supply to liver tumors
  • Radiofrequency ablation (RFA) and microwave ablation use heat to destroy small liver tumors
  • Minimally invasive options for patients not suitable for surgery

Managing Treatment and Living with the Disease

Living with neuroendocrine carcinoma involves more than just receiving medical treatments—it requires attention to overall well-being, symptom management, and emotional health. Many patients find that staying active and maintaining good nutrition helps them tolerate treatments better and maintain their quality of life^[16]. Even simple activities like taking regular walks can help reduce fatigue, improve mood, and maintain strength during treatment.

For patients with functional neuroendocrine carcinomas, dietary modifications may help control symptoms. Some foods and drinks can trigger uncomfortable symptoms like facial flushing, severe diarrhea, or rapid heartbeat in people whose tumors produce excess hormones. Foods high in compounds called amines—such as aged cheeses, chocolate, red wine, beer, smoked meats, and fermented foods—may worsen symptoms^[20]. Keeping a food diary can help identify personal triggers. Many patients benefit from eating smaller, more frequent meals rather than large meals, and avoiding fatty, greasy, or highly spicy foods that may aggravate digestive symptoms.

The emotional impact of living with a chronic cancer diagnosis cannot be underestimated. Many patients describe their experience as a roller coaster of emotions, with periods of feeling relatively normal alternating with anxiety about the future^[16]. It’s completely normal to feel scared, angry, sad, or overwhelmed at times. Some people find comfort in talking with family and friends, while others prefer speaking with a counselor or joining a support group where they can connect with others facing similar challenges. Many cancer centers offer psychological support services, and online communities provide opportunities to share experiences and find encouragement.

Regular follow-up care is essential for monitoring the disease and adjusting treatment as needed. After completing initial treatment, patients typically have appointments every few months that may include physical examinations, blood tests to check hormone levels and other markers, and imaging scans to look for any signs of cancer growth or spread^[13]. These appointments can feel stressful, but they’re important for catching any problems early when they’re most treatable. Preparing questions in advance and bringing someone along to appointments can help you get the most from these visits.

Many patients with neuroendocrine carcinomas continue to work, travel, and participate in activities they enjoy even while undergoing treatment^[19]. With proper management, symptom control, and support from healthcare teams, maintaining an active and fulfilling life is possible. Each person’s experience is unique, and finding the right balance between treatment, rest, and activity takes time and adjustment.